Alexandre de Germay - Feb 27, 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role: Executive Vice President
Signature: Susan E. Grant, by power of atty., for Alexandre de Germay
Stock symbol: PFE
Transactions as of: Feb 27, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/28/2024, 04:58 PM
Previous filing: Dec 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Award	$0	+74.4K		$0.00	74.4K	Feb 27, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+89.5K		$0.00	89.5K	Feb 27, 2024	Common Stock	89.5K	$26.89	Direct	F2
transaction	PFE	Stock Appreciation Rights	Award	$0	+79.1K		$0.00	79.1K	Feb 27, 2024	Common Stock	79.1K	$26.89	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.